CD40 Ligand

CD40 Ligand

CD40 Ligand 詳細

Molecule Name
CD40 ligand
分子の別称
CD40LG,CD154,CD40L,HIGM1,IGM,IMD3,T-BAM,TNFSF5,TRAP,gp39
Drug Development Progress
治験薬の数14
市販薬剤の数0
研究&開発段階Phase 3 Clinical
ターゲットの別称
CD154 Antigen,HCD40L,CD154,TNFSF5,CD40L,CD40 ligand, soluble form,CD40 ligand, membrane form,Tumor necrosis factor ligand superfamily member 5,T-cell antigen Gp39,CD40-L,CD40LG,TNF-Related Activation Protein,Tumor Necrosis Factor (Ligand) Superfamily Member 5,T-B Cell-Activating Molecule,T-BAM,HIGM1,Gp39,IMD3,IGM,CD40 Ligand,CD40 Antigen Ligand,TRAP,Tumor Necrosis Factor (Ligand) Superfamily, Member 5 (Hyper-IgM Syndrome),Hyper-IgM Syndrome,sCD40L
バックグランド
CD40 ligand is also known as CD40L, CD154, TNFSF5 and T-cell antigen Gp39, is a single-pass type I I membrane protein which belongs to the TNF superfamily of molecules. CD40 ligand is expressed predominantly on activated CD4+ T lymphocytes, and also found in other types of cells, including platelets, mast cells, macrophages, basophils, NK cells, B lymphocytes, as well as non-haematopoietic cells (smooth muscle cells, endothelial cells, and epithelial cells). Although all monomeric, dimeric and trimeric forms of soluble CD40 ligand can bind to CD40, the trimeric form of soluble CD40 ligand has the most potent biological activity through oligomerization of cell surface CD40, a common feature of TNF receptor family members. CD40 ligand binds to CD40 on antigen-presenting cells (APC), which leads to many effects depending on the target cell type. In general, CD40 ligand plays the role of a costimulatory molecule and induces activation in APC in association with T cell receptor stimulation by MHC molecules on the APC. In total CD40 ligand has three binding partners: CD40, α5β1 integrin and αIIbβ3. CD40 ligand regulates B cell function by engaging CD40 on the B cell surface. A defect in this gene results in an inability to undergo immunoglobulin class switch and is associated with hyper IgM syndrome.

CD40 Ligand 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Dapirolizumab pegolAnti-CD40L-Fab; Anti-CD40L-Fab-PEG; CDP-7657; CD40L - Fab; BIIB-133Phase 3 ClinicalBiogen Inc, Ucb
Autoimmune Diseases; Connective Tissue Diseases; Immune System Diseases; Lupus Erythematosus, Systemic; Skin and Connective Tissue Diseases
詳細
DazodalibepVIB-4920; MEDI-4920; HZN-4920(Horizon Therapeutics); UNII-HN5US76BWF; WHO-11399Phase 3 ClinicalHorizon Therapeutics PLC, Medimmune Llc
Arthritis, Rheumatoid; Graft Rejection; Lupus Nephritis; Rejection of renal transplantation; Sjogren's Syndrome; Sjogren-Larsson Syndrome
詳細
FrexalimabINX-021; SAR-441344Phase 3 ClinicalImmunext Inc
Diabetes Mellitus, Type 1; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Lupus Erythematosus, Systemic; Multiple Sclerosis; Nephrosis; Rejection of renal transplantation; Sjogren's Syndrome; Sjogren-Larsson Syndrome
詳細
Anti-CD40L antibody (Bristol-Myers Squibb)Phase 2 ClinicalBristol-Myers Squibb Company
Immunologic Deficiency Syndromes
詳細
TegoprubartAT-1501Phase 2 ClinicalAls Therapy Development Institute
Amyotrophic Lateral Sclerosis; Diabetes Mellitus, Type 1; Glomerulonephritis, IGA; Rejection of renal transplantation
詳細
Delolimogene mupadenorepvecLOAd-703Phase 2 ClinicalLokon Pharma, Uppsala University
Biliary Tract Neoplasms; Colorectal Neoplasms; Melanoma; Ovarian Neoplasms; Pancreatic Neoplasms
詳細
TNX-1500TNX-1500Phase 2 ClinicalTonix Pharmaceuticals Holding Corp
Autoimmune Diseases; Autoimmune Diseases of the Nervous System; Rejection of renal transplantation; Rejection of organ transplantation
詳細
Base-edited hematopoietic stem and progenitor cells therapy (NIAID)Phase 2 ClinicalNational Institute Of Allergy And Infectious Diseases (Niaid)
Hyper-IgM Immunodeficiency Syndrome, Type 1
詳細
CD40 ligand expressing MSLN-CAR T cellsPhase 2 ClinicalPla General Hospital
Solid tumours
詳細
LetolizumabBMS-986004; BMS2h-572-633-CT-L2Phase 1 ClinicalBristol-Myers Squibb Company
Graft vs Host Disease; Purpura, Thrombocytopenic, Idiopathic
詳細
MEM-288MEM-288Phase 1 ClinicalMemgen
Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
詳細
IBI355IBI-355Phase 1 Clinical
Lupus Erythematosus, Systemic; Sjogren's Syndrome
詳細
CD40L-augmented Tumor Infiltrating Lymphocytes (H Lee Moffitt Cancer Center & Research Institute)Phase 1 ClinicalH Lee Moffitt Cancer Center & Research Institute
Carcinoma, Non-Small-Cell Lung
詳細
Lu-AG22515APB-A1; Lu-AG22515Phase 1 ClinicalAprilBio Co Ltd
Graves Ophthalmopathy; Neuromyelitis Optica
詳細